Results 261 to 270 of about 2,398,808 (296)

Antibody-drug conjugates

2012
GERBER HANS-PETER, DIJOSEPH JOHN FRANCIS, KHANDKE KIRAN MANOHAR, MARQUETTE KIMBERLY ANN, SAPRA PUJA, TCHISTIAKOVA LIOUDMILA GENNADIEVNA   +5 more
openaire   +6 more sources

How Far Have We Developed Antibody–Drug Conjugate for the Treatment of Cancer?

Drugs and Drug Candidates, 2023
Sharina Hamzah, Hui Yin Yow, Shi Xuan Low   +2 more
exaly  

New Senolysis Approach via Antibody–Drug Conjugate Targeting of the Senescent Cell Marker Apolipoprotein D for Skin Rejuvenation

International Journal of Molecular Sciences, 2023
Kento Takaya, Kazuo Kishi
exaly  

Sacituzumab govitecan, a novel, third-generation, antibody-drug conjugate (ADC) for cancer therapy

Expert Opinion on Biological Therapy, 2020
Robert Sharkey, David M Goldenberg
exaly  

Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review

Cancers, 2021
Vito Carlo Alberto Caponio, Emily Capone, Vittoria Perrotti   +2 more
exaly  

Quantification of an Antibody-Conjugated Drug in Fat Plasma by an Affinity Capture LC-MS/MS Method for a Novel Prenyl Transferase-Mediated Site-Specific Antibody–Drug Conjugate

Molecules, 2020
Byeongill Lee, Young Shin, Yun-Hee Park   +2 more
exaly  

Preferential Antibody and Drug Conjugate Targeting of the ADAM10 Metalloprotease in Tumours

Cancers, 2022
Linda Hii, Simon Wilkins, Mary Vail
exaly  

What makes a good antibody–drug conjugate?

Expert Opinion on Biological Therapy, 2021
exaly  

The Second Generation Antibody-Drug Conjugate SYD985 Overcomes Resistances to T-DM1

Cancers, 2020
Santiago Escrivà de Romaní, Cristina Saura Manich, Joaquin Arribas   +2 more
exaly  

Antibody drug conjugates

2022
XU HE, LEE HONG MYUNG, ARENDT CHRISTOPHER   +2 more
openaire   +5 more sources